Introduction Erdosteine [ N-（ carboxymethylthioacetyl ）-homocysteine thiolactone ] （ Fig. 1 ） is a synthetic derivative of natural amino acid methionine. It has been commonly used in clinical practice as a mucoly...Introduction Erdosteine [ N-（ carboxymethylthioacetyl ）-homocysteine thiolactone ] （ Fig. 1 ） is a synthetic derivative of natural amino acid methionine. It has been commonly used in clinical practice as a mucolytic drug and as an enhancer of respiratory ventilation in the treatment of patients with chronic obstructive respiratory disease. Erdosteine contains 2 blocked sulfhydryl groups, which are released after metabolic transformation in the liver. The liberated sulfhydryl groups break the disulphide bonds, which hold the glycoprotein fibres of mucus together; this makes the bronchial secretions more fluid and allows more rapid elimination. The reducing potential of these sulfhydryl groups accounts for the free radical scavenging and antioxidant properties of erdosteine.展开更多
基金Supported by the National Nature Science Foundation of China(No.39930180).
文摘Introduction Erdosteine [ N-（ carboxymethylthioacetyl ）-homocysteine thiolactone ] （ Fig. 1 ） is a synthetic derivative of natural amino acid methionine. It has been commonly used in clinical practice as a mucolytic drug and as an enhancer of respiratory ventilation in the treatment of patients with chronic obstructive respiratory disease. Erdosteine contains 2 blocked sulfhydryl groups, which are released after metabolic transformation in the liver. The liberated sulfhydryl groups break the disulphide bonds, which hold the glycoprotein fibres of mucus together; this makes the bronchial secretions more fluid and allows more rapid elimination. The reducing potential of these sulfhydryl groups accounts for the free radical scavenging and antioxidant properties of erdosteine.
